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.2013.07Abstract Objective: To investigate whether peri-operative risk stratiﬁcation of children with ven-
tricular septal defect (VSD) and complete atrioventricular septal defect (CAVSD) complicated with
elevated pulmonary vascular resistance could be predicted solely based on measuring systemic oxy-
gen saturation (SaO2) without performing cardiac catheterization.
Methods: Records of patients with VSD and CAVSD, who underwent cardiac catheterization from
2002 to 2012 were reviewed and grouped as low (A) and high (B) risk, based on the pulmonary vas-
cular resistance (PVRI) of 6 or >6 Woods units (WU) in room air, respectively. Patients in group
B underwent oxygen study to assess pulmonary vascular reactivity. Patients with PVRI 6 6 WU in
either room air or on 100% oxygen were deemed operable.
Results: Seventy-six patients; (VSD = 45, CAVSD= 31) underwent measurement of pulmonary
vascular resistance. All patients with VSD were operated. Forty-two of them had systemic oxygen
saturation (SaO2)P 94%. Twenty-four of 31 patients with CAVSD were operated and hadDepartment of Pediatrics,
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64 S. Deraz et al.SaO2P 83%. SaO2 ofP83% in CAVSD andP94% in VSD had sensitivity and speciﬁcity of 95%
and 100%, respectively to predict pulmonary vascular resistance based operability.
Conclusion: Oxygen saturation on pulse oximetry of P94% in children with VSD and 83% with
CAVSD accurately identiﬁed operable patients. This criterion may be used as an alternate to inva-
sive assessment of pulmonary vascular resistance. Outcome of operable patients having
PVRI > 6 WU in room air is good and similar to those with PVRI < 6 WU.
ª 2013 Production and hosting by Elsevier B.V. on behalf of The Egyptian Pediatric Association.Introduction
Pulmonary vascular obstructive disease (PVOD) is known
to adversely affect the outcome of patients with ventricular
septal defect (VSD) and complete atrioventricular septal
defect (CAVSD).1–3 Those having CAVSD, especially in
the presence of Down’s syndrome are prone to develop pro-
gressive pulmonary vascular obstructive disease (PVOD)
even during infancy.1,3,4 Since pulmonary vascular disease
progresses over time, early repair of these defects has
remarkably improved the outcome by preventing the
development of pulmonary vascular disease.5 However, late
referral to tertiary care centers is still a persisting problem
in the developing countries.6,7 Since January 2002, we
adopted a policy of measuring pulmonary vascular resistance
by cardiac catheterization for all patients P6 months of age
with VSD and CAVSD who had near systemic level
pulmonary hypertension by echocardiographic evaluation.
Cardiac catheterization was also performed in patients
younger than 6 months of age if systemic arterial oxygen
saturation (SaO2) was lower than expected (<85% for
CAVSD and < 94% for VSD).8
In this study we aimed to review, if operability in such pa-
tients could be established without performing cardiac cathe-
terization and also to evaluate impact of severity of
pulmonary vascular obstructive disease on immediate and
mid-term postoperative outcome.
Patients and methods
Patient population
The study was done in King Faisal Specialist Hospital and Re-
search Center – Jeddah. The Institutional Review Board ap-
proved the present retrospective study. Informed consent for
retention and use of patient data for scientiﬁc purposes was
routinely obtained at the same time of any hospital admission.
Eighty-ﬁve patients; 47 having VSD and 38 with CAVSD
underwent measurement of pulmonary vascular resistance.
Mean age and weight for VSD group were 3.5 ± 2.9 yearsatrial septal defect; CAVSD,
ICU, intensive care unit; LAP,
ilation; NO, nitric oxide; PAP,
P, pulmonary artery systolic
; PSPG, peak systolic pressure
, pulmonary vascular obstruc-
r resistance; Pump T, pump
ic ﬂow; RV, right ventricle;
ex; SaO2, oxygen saturation;
ntricular septal defect; WU,
e; 2D, two dimensional.and 11 ± 5.7 kg, respectively and 2.9 ± 3.8 years and
10.5 ± 9.3 kg, respectively for CAVSD. All patients with the
diagnosis of VSD and CAVSD having near systemic level pul-
monary hypertension on echocardiographic evaluation and
who underwent hemodynamic evaluation by cardiac catheter-
ization between 2002 and 2012 constituted the study popula-
tion. Patients with moderately impaired left ventricular
systolic function, severe mitral regurgitation, more than mod-
erate aortic insufﬁciency, and complete heart block after surgi-
cal repair were excluded.
Patients were divided into two groups; group A (low risk)
with PVRI < 6 Wood units/m2 and group B (high risk) with
PVRIP 6 Wood units/m2 in room air. Medical records were
reviewed to obtain demographic, echocardiographic and car-
diac catheterization, and relevant surgical and postoperative
data.
Echocardiogram
Peri-operative studies were reviewed to assess left ventricular
systolic function. All patients had an echocardiogram done
at least 3 months before the surgical procedure and on the
second day postoperatively. Systolic left ventricular function
was assessed by visual assessment of two dimensional (2 D)
images and graded as mild, moderately, or severely impaired
according to the standard practice.9 In addition to the
visual assessment, systolic left ventricular function was
assessed by measuring the fractional shortening according
to the following formula: Fractional shortening %
(FS) = (LVEDD  LVESD)/LVEDD · 100, where LVEDD
is the left ventricular end diastolic dimensions, LVESD is
the left ventricular end systolic dimensions. Any value below
28% was considered reduced ventricular function.10
Using echocardiography in two different views (apical four
chamber and subxiphoid views) right ventricular volume visu-
ally evaluated by at least two different pediatric cardiologists,
and tricuspid anulus dimension were measured. Tricuspid anu-
lus dimension of more than 1.0 cm/m2SA was considered ade-
quate for biventricular repair.11 All four cardiac valves were
interrogated for stenosis and regurgitation using Doppler
imaging. Valvular insufﬁciency was qualitatively graded as
mild, moderate, and severe based on color ﬂow mapping
according to the guidelines of American Society of Echocardi-
ography,10 using para-sternal long and short axes and apical
four-chamber views.
Cardiac catheterization
Patients were deemed eligible for catheterization only if they
were cleared from any acute illness and chest X-ray showed
no parenchymal abnormalities. Studies were performed under
Figure 1 Algorithm of the studied patients.
Figure 2A Receiver operative characteristic curve for
SaO2P 94% in VSD group to predict operability. Sensitivity
and speciﬁcity of SaO2P 94% was 95% and 100% respectively.
Figure 2B Receiver operative characteristic curve for
SaO2P 83% in CAVSD group to predict operability. Sensitivity
and speciﬁcity of SaO2P 83% was 95% and 100% respectively.
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and occasionally Fentanyl. Pulmonary (Qp) and systemic
(Qs) blood ﬂows were calculated by applying Fick principal
and using assumed oxygen consumption. When pulmonary
veins were not directly sampled, pulmonary venous oxygen
saturation was assumed to be 98% in room air and equal
to that in the aorta or left ventricle in 100% oxygen. Pulmon-
ary vascular reactivity was tested with 100% oxygen inhala-
tion through a non-rebreather face mask for 10 min, if
pulmonary vascular resistance index (PVRI) was P6 Wood
units in room air. Left atrial pressure was either measured
directly or estimated from left ventricular end-diastolic pres-
sure if the left atrium was not accessed. PVRI and systemic
vascular resistance (SVRI) were calculated using standard
formula and a PVRI of >3 Wood units/m2 was considered
as elevated.12Operative and postoperative care
Surgical repair was performed under cardiopulmonary bypass
and moderate hypothermia (32 C) by two surgeons. Postoper-
atively, all patients with elevated pulmonary vascular resis-
tance were treated as high risk for the development of
pulmonary hypertensive crises. Patients were sedated with
Fentanyl and midazolam. Muscular paralysis with non-depo-
larizing agents was induced in few cases as per discretion of
intensive care team. Mild hyperventilation was maintained
for at least 24 h. The arterial PH was kept between 7.4 and
7.5. Peripheral arterial line was placed in all patients and sys-
temic pressure was continuously monitored. Pulmonary artery
pressure was not recorded as none of the patients had pulmon-
ary artery catheter.
Table 1 Baseline characteristics and hemodynamic data.
VSD AVSD
Low risk (n= 23) High risk (n= 22) P value Low risk (n= 15) High risk (n= 9) P value
Age (yrs) 3.6 ± 2.9 3.4 ± 3.1 0.8 2.7 ± 2.9 3.2 ± 5.2 0.8
Weight (kg) 11 ± 5.4 10.3 ± 6 0.6 9.9 ± 6.3 11.5 ± 13.5 0.68
SaO2 (room air) 97 ± 1.7 95 ± 3.5 0.1 95 ± 5.1 84 ± 6.1 0.0005
Qp (L/min/m2) 11.8 ± 3.4 6.1 ± 1.7 0.001 11.5 ± 3.9 5.5 ± 1.4 0.0005
Qs (L/min/m2) 4.4 ± 1.4 3.7 ± 1.1 0.1 6.1 ± 8.9 3.7 ± 1.0 0.43
Qp/Qs 2.9 ± 1.3 1.8 ± 0.5 0.0005 2.9 ± 1.3 1.6 ± 0.6 0.01
PAP mean (mmHg) 46.7 ± 12.9 61 ± 12.9 0.0005 42.3 ± 13.5 62.2 ± 9.0 0.001
LAP mean (mmHg) 12 ± 3.1 10.6 ± 3.6 0.22 10.3 ± 4.1 11.4 ± 4.0 0.6
PVRI (WU/m2) 3.2 ± 1.3 8.7 ± 2.9 0.0005 3.2 ± 1.6 10.3 ± 4.1 0.001
SVRI WU/m2 17.1 ± 7.9 18.7 ± 4.9 0.47 4 ± 1.2 5.5 ± 1.8 0.45
PVRI/SVRI 0.2 ± 0.1 0.5 ± 0.1 0.0005 0.3 ± 0.2 0.7 ± 0.4 0.01
VSD: ventricular septal defect, AVSD: atrioventricular septal defect, yrs: years, kg: kilogram, SaO2: oxygen saturation, Qp: pulmonary vascular
resistance, Qs: systemic vascular resistance, PAP: pulmonary artery pressure, LAP: left atrial pressure, PVRI: pulmonary vascular resistance
index, SVRI: systemic vascular resistance index.
66 S. Deraz et al.Statistical analysis
Student’s t-test was used to compare the hemodynamic data,
intraoperative and postoperative variables including pump
time, cross clamp time, mechanical ventilation and inotroic
support duration, intensive care and hospital stay of the
high risk group with the low risk group. Paired t-test was
used to compare change in pulmonary ﬂow, systemic ﬂow,
pulmonary artery and left atrial pressures, PVRI, Systemic
vascular resistance index (SVRI), and PVRI/SVRI ratio with
100% oxygen in high risk groups. Receiver operator curves
were generated to estimate sensitivity and speciﬁcity of oxy-
gen saturation measured by pulse oximetry to predict oper-
ability. The gold standard for the sensitivity and speciﬁcity
of oxygen saturation was the drop of PVRI after giving
100% oxygen.
Results
Eighty-ﬁve patients; 47 having VSD and 38 with CAVSD
underwent measurement of pulmonary vascular resistance
(Fig. 1) Mean age and weight for the VSD group were
3.5 ± 2.9 years (range 0.5–10 years, median = 3.2 years)
and 11 ± 5.7 kg (median = 10.1 kg) respectively and
2.9 ± 3.8 years (0.3–17 years, median = 3.8 years) and
10.5 ± 9.3 kg (median = 12.1 kg) respectively for CAVSD.
One patient was <6 months in this series. He had CAVSD
and underwent cardiac catheterization because his SaO2 was
83% on room air. Thirty-ﬁve patients (74%) in the VSD group
and 17 (44%) in the CAVSD group were older than 1 year. All
patients in the VSD group were deemed operable; 23 patients
belonged to group A and 24 were in group B. All but three pa-
tients in the VSD group had systemic SaO2P 94%, their oxy-
gen saturations were 88%, 89%, and 90%. In the CAVSD
group 34/38 patients were deemed operable based on PVRI
criteria. All patients in CAVSD group, meeting the criteria
of operability had SaO2P 83%. Of these 15 were in group
A and 9 belonged to group B. The four inoperable cases had
oxygen saturations of 71%, 75%, 76%, and 80%. Surgery
was not performed in another 6 patients for non-medicalreasons. Thus 28 patients in this group underwent surgical re-
pair. Medical records of 2 in the VSD group and 4 patients in
the CAVSD group were incomplete, leaving 45 patients in
VSD and 24 in CAVSD group for outcome analysis. All of
these patients had signs and symptoms suggestive of congestive
heart failure. Our data showed that in the VSD group, the sen-
sitivity and speciﬁcity of Oxygen saturation P94% were 95%
and 100% respectively, (Fig. 2A). In the CAVSD group sensi-
tivity and speciﬁcity of Oxygen saturation P83% were 95%
and 100% respectively, (Fig. 2B).
Echocardiographic data
Preoperative studies showed that right ventricle (RV) was
smallish though adequate for biventricular repair in 4/47 pa-
tients (8.5%) in VSD and 1/37 (2.5%) in CAVSD group. Left
ventricular systolic function was normal in all patients except
in one in VSD and two in CAVSD group. Postoperatively,
two patients in the CAVSD group had mildly reduced left ven-
tricular systolic function. The remaining patients had normal
left ventricular systolic function. In the immediate postopera-
tive period (ﬁrst day postoperative), 1(2%) in VSD and
3(12%) in CAVSD group had severe tricuspid regurgitation
that reduced to moderate degree on follow up. None of the pa-
tients in VSD and 1(4%) in CAVSD group developed moder-
ate to severe mitral regurgitation, which persisted on further
follow up but without any clinical decompensation. None of
the patient had severe pulmonary or more than mild aortic
insufﬁciency.
Cardiac catheterization data
Among the operated patients, the mean pulmonary artery
pressure and PVRI in room air were signiﬁcantly higher in
group B (high risk) compared to group A (low risk) in both
VSD group [62.5 ± 13 mmHg versus 47 ± 13 mmHg,
(p= 0.005) and 9.3 ± 3.3 WU/m2 versus 3.2 ± 1.3 WU/m2,
(p= 0.005)] and CAVSD group [62 ± 9 mmHg versus
42 ± 13 mmHg, (p= < 0.001) and 10.3 ± 4 WU/m2 versus
3.2 ± 1.6 WU/m2, (p= 0.001)] respectively. Pulmonary blood
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Figure 3 Hemodynamic changes on 100% oxygen in high risk VSD group.
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also signiﬁcantly higher in low risk group compared to high
risk group in both VSD and CAVSD groups (Table 1). After
inhalation of 100% oxygen the PVRI dropped from
9.4 ± 3.4 WU/m2 to 3.15 ± 1.4 WU/m2 in high risk group
with VSD (Fig. 3, Table 4) and from 9.4 ± 3.4 WU/m2 to
3.15 ± 1.4 WU/m2 in high risk group with CAVSD (Fig. 4,
Table 4). This drop was mainly because of the increase in pul-
monary blood ﬂow. Four patients in CAVSD group who were
deemed inoperable had mean PVRI 18 WU/m2 in room air
that dropped to only 7.9 WU/m2 on 100% oxygen (Tables 2
and 3).Operative and postoperative course
Cardiopulmonary bypass time and cross clamp time were
similar in the two groups. Postoperatively all patients were
in sinus rhythm. Duration of inotropic support, pulmonary
vasodilator therapy, mechanical ventilation, and number of
chest tube days were similar in the two groups. Duration of
ICU stay was somewhat longer for patients in group B
(high risk) but the difference was not statistically signiﬁcant
(Table 5). Nitric oxide inhalation was used for three
patients with CAVSD and all of them did well
postoperatively.
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68 S. Deraz et al.Follow up
One patient died within 30 days post-surgery, this was a case of
Down syndrome with AVSD who developed sepsis and dis-
seminated intravascular coagulopathy (DIC) in the ICU. Se-
ven more patients died during follow up (range: 1–
24 months), making total mortality of 11% (Table 6). Threehad CAVSD (two from high risk), one case expired 6 month
postoperatively and the other two cases expired 24 months
postoperatively. The case of death in these three cases was
non-cardiac. Four has VSD (three in high risk and one in
low risk group). Three of them expired 1.5 month postopera-
tively. Two of these cases developed pulmonary hypertensive
crisis and were treated in ICU by nitric oxide inhalation and
Table 2 Preoperative echocardiographic data.
VSD AVSD
IVSD (mm) 4.7 ± 1.3 5.1 ± 2.3
LVPWD (mm) 5.4 ± 2.2 5.3 ± 1.9
LVEDD (mm) 30.1 ± 3.9 32.2 ± 4.9
FS (%) 31.3 ± 4.8 32.1 ± 5.4
TR (PG) 67 ± 13.4 69.3 ± 12.9
Smallish RV size 4 (8.5%) 1 (2.5%)
IVSD: interventricular septal dimensions, LVPWD: left ventricular
posterior wall dimensions, LVEDD: left ventricular end diastolic
dimensions, FS: fractional shortening, TR: tricuspid regurge: PG:
pressure gradient, RV: right ventricle.
Table 3 Post operative echocardiographic data.
VSD AVSD
IVSD (mm) 4.8 ± 1.5 5.4 ± 2.1
LVPWD (mm) 5.6 ± 2.1 5.6 ± 2.2
LVEDD (mm) 29.5 ± 2.7 33.2 ± 2.8
FS (%) 33.6 ± 5.1 32.7 ± 3.8
TR (PG) 59 ± 12.6 61 ± 9.7
TR (right AVV regurge) 1 (2%) 3 (12%)
MR (left AVV regurge) 0 (0%) 1 (4%)
IVSD: interventricular septal dimensions, LVPWD: left ventricular
posterior wall dimensions, LVEDD: left ventricular end diastolic
dimensions, FS: fractional shortening, TR: tricuspid regurge: AVV:
atrioventricular valve.
Predicting operability in children with acyanotic congenital heart diseases and severe pulmonary hypertension 69hyperventilation, however treatment was not successful. The
other 2 cases expired due to non-cardiac causes. Twelve pa-
tients were lost to follow up either because of living in other
countries or lack of access to medical care.
Discussion
Systemic oxygen saturation (SaO2) in patients having congen-
ital heart diseases with left to right shunts begin to decrease
gradually from baseline as they develop increasing PVOD
resulting in right to left shunting.8 We hypothesized that
SaO2 may assist in determining operability in these patientsTable 4 Hemodynamic response to oxygen in high risk patients un
VSD (n= 19)
Room air 100% Oxygen
Qp 5.9 ± 1.6 17.8 ± 11.1
Qs 5.3 ± 1.5 4.4 ± 1.5
Mean PAP (mmHg) 62 ± 13 58.3 ± 12.5
Mean LAP (mmHg) 11.2 ± 3.6 13.6 ± 4.1
PVRI(WU/m2) 9.6 ± 3.3 3.2 ± 1.5
PVRI/SVRI 0.43 ± 0.13 0.19 ± 0.11
VSD: ventricular septal defect, AVSD: atrioventricular septal defect, Qp:
pulmonary artery pressure, LAP: left atrial pressure, PVRI: pulmonary vas
Wood’s unit.without performing cardiac catheterization. In this series, we
reviewed hemodynamic data of patients with VSD and CAV-
SD to determine whether SaO2 measured by pulse oximetry
could correctly identify patients who would be declared oper-
able or inoperable based on PVRI measured by cardiac
catheterization.
Irreversible PVOD is generally not seen below 2 years of
age in patients with VSD and below 6 months of age in cases
of CAVSD. Majority of such patients generally undergo suc-
cessful surgical repair earlier in life without preoperative
assessment of PVOD. However, the exceptions are not very
uncommon, especially in the case of CAVSD, where PVOD
generally progresses relatively early, more so in association
with Down syndrome. Even very young infants with CAVSD
and young children with large VSD occasionally develop se-
vere elevation of PVRI with grade 3 to 4 Heath-Edwards pul-
monary vascular changes and therefore, would not be a
suitable candidate for surgical repair. On the other hand many
older children and some adolescents with same congenital
heart diseases show only mild elevation of PVRI and only
grade 2 pulmonary vascular changes and qualify for
surgery.3,8,13,14
An essential aspect of the management of patients sus-
pected to have PVOD is to identify those with irreversible
pulmonary vascular disease in whom surgical repair is contra-
indicated.8,13,15 This can be done indirectly by measuring
pulmonary vascular resistance during cardiac catheteriza-
tion.3,16,17 Although a uniform consensus is lacking, in most
centers, a patient is considered operable if the PVRI drops
to 66 Wood units on vasoreactivity testing with 100% oxygen
inhalation with or without nitric oxide, irrespective of PVRI in
room air.14
Out of 84 patients suspected of having signiﬁcantly elevated
PVRI, it was either normal or <6 WU/m2 in room air in 45
(53.5%) patients. All but one patient in the CAVSD group
who were declared operable based on PVRI criterion had
SaO2 ofP83% by pulse oximetry and four patients who were
declared inoperable had SaO2 ranging from 75% to 81%. In
the VSD group, all patients were declared operable, all but
three had SaO2P 94%. In a retrospective study David
et al.18 showed that PVRI/SVRI ratio of <0.33 in room air
or while breathing 100% oxygen or nitric oxide (NO) is a reli-
able indicator of operability in patients with elevated PVRI.
They also showed that NO inhalation could further allow
the identiﬁcation of operable patients among those with
PVRI/SVRI ratio >0.33 while 100% oxygen inhalation woulddergone surgery.
AVSD (n= 9)
P value Room air 100% Oxygen P value
0.0005 5.1 ± 1.5 18.4 ± 8.8 0.0005
0.5 4.4 ± 1.9 4.3 ± 1.3 0.9
0.05 64.6 ± 7.4 59.6 ± 10.9 0.05
0.0005 9.7 ± 4.4 11 ± 4.5 0.07
0.0005 9.4 ± 3.4 3.15 ± 1.4 0.0005
0.001 0.74 ± 0.33 0.27 ± 0.19 0.0005
pulmonary vascular resistance, Qs: systemic vascular resistance, PAP:
cular resistance index, SVRI: systemic vascular resistance index, WU:
Table 6 Some demographic, clinical and hemodynamic ﬁndings of the expired cases.
Age (yrs) Diagnosis SaO2 PVR (air) PVR (O2) Timing of death after surgery (months)
2.5 CAVSD, PDA, ASD II 94 1.5 24
1.25 CAVSD 100 2.7 24
1.16 CAVSD, PDA 88 12 2.4 6
1.16 CAVSD, PDA 76 6.4 1.2 1
1 VSD 90 6.8 1.5
4 VSD, PDA 100 3 1.5
0.9 VSD, coarctation of the aorta 90 11 2.2 10
3 VSD 98 16.4 4.4 1.5
SaO2: oxygen saturation, PVR: pulmonary vascular resistance.
Table 5 Post operative outcome in both groups.
VSD AVSD
Low risk (n= 23) High risk (n= 24) P value Low risk (n= 16) High risk n= 9 P value
Pump time (min) 93 ± 3.3 111.4 ± 98.7 0.45 122 ± 37.3 163.7 ± 130.4 0.37
X-clamp time (min) 69.2 ± 32.4 75.5 ± 82.3 0.74 97 ± 31.6 113 ± 44.5 0.31
MV (h) 31.3 ± 83.3 71.2 ± 136.7 0.23 54.9 ± 103.3 71.8 ± 70 0.67
Dopamine (h) 27.4 ± 87.0 32.2 ± 58.5 0.83 42.2 ± 105.2 15.7 ± 20.3 0.46
Dobutamine (hrs) 20.3 ± 71.6 15.5 ± 21.7 0.78 38.5 ± 88 32.4 ± 40 0.84
Epinephrine (hrs) 8.7 ± 14.4 51.5 ± 113.4 0.1 3.4 ± 9.2 15.4 ± 33.6 0.32
PGE1 (hrs) 6.7 ± 11.0 18.0 ± 25.4 0.08 11 ± 20 5 ± 10 0.42
ICU stay (days) 3.9 ± 4.0 6.8 ± 9.5 0.18 5.1 ± 5 8.6 ± 6.3 0.14
Hospital stay (days) 9.6 ± 3.3 13.9 ± 12.4 0.11 13.3 ± 11.4 13.8 ± 4 0.9
VSD: ventricular septal defect, AVSD: atrioventricular septal defect, min: minute, MV: mechanical ventilation, hrs: hours, PGE1: prostaglandin
E1, ICU: intensive care unit.
70 S. Deraz et al.therefore have been incorrectly declared inoperable. In our ser-
ies PVRI/SVRI ratio could be measured in 84 patients, but
only 69 patients were included in the statistical analysis (see
Fig. 1), in room air (Table 1) and in 100% oxygen in 29 pa-
tients. Those, who were declared operable had a ratio of
<0.33 either in room air (28 patients) or in 100% oxygen
(24 patients), (Table 4). Four patients with CAVSD, declared
inoperable by SaO2 and PVRI criteria had a ratioP0.45. Thus
our data not only conﬁrm their ﬁndings but also show that if
the SaO2 is P94% in VSD patients and P83%, their PVRI
will be 66 WU/m2 and PVRI/SVRI will be 60.33 either in
room air or in 100% 0xygen. Using receiver operative curve,
the sensitivity and speciﬁcity of SaO2P 83% to identify oper-
able patients based on PVRI criterion were 95% and 100%,
respectively and in the CAVSD group and sensitivity and spec-
iﬁcity of SaO2P 94% to identify operable patients with VSD
were 95% and 100%, respectively. Thus using pulse oximetry
data we could correctly identify operable patients. We believe
that this is an important observation as nearly all operable
patients could have been referred for surgical repair without
performing cardiac catheterization. Such an approach will
not only avoid potential complications of cardiac
catheterization,19,20 but also allow better time utilization of
catheterization laboratory, assisting staff including doctors,
and hospital beds in addition of saving the cost of cardiac
catheterization, which approximates 2100 US$/patient in our
center. Historically, PVRI was routinely measured for all
patients with CAVSD, large VSD and patent ductus
arteriosus (PDA). Overtime, with increasing expertise, betternon-invasive echocardiographic imaging, and improved peri-
operative care, the value of preoperative hemodynamic assess-
ment was questioned.15 Zellers et al.21 recommended to offer
complete repair to all infants 61 year of age with CAVSD
without hemodynamic evaluation by cardiac catheterization
but warned against extrapolating their results and recommen-
dations to older patients because of the concern of pulmonary
vascular obstructive disease and poor surgical outcome. Our
data suggest that the same can be applied to children up to
10 years of age with both CAVSD and VSD as long as they
meet the pulse oximetry criteria of operability. We could cor-
rectly classify even a 17 year old with CAVSD and Down’s
syndrome to be operable by these criteria. This patient is doing
very well, off any medication and without residual pulmonary
hypertension. Another important observation made in our
study was the similar surgical outcome of all operable patients,
irrespective of elevation of PVRI with respect to need for ino-
tropic support, mechanical ventilation, hospital stay, and
thirty day mortality. Intensive care stay was slightly longer
for high risk group but was not statistically different. Thus pre-
operative knowledge of elevated pulmonary vascular resistance
in operable patients did not inﬂuence the postoperative man-
agement and outcome. These encouraging results in a histori-
cally high risk group are the consequence of better
understanding of pulmonary hypertension pathophysiology,
improved surgical techniques, including myocardial protection
during cardiopulmonary bypass, postoperative intensive care,
and availability of therapeutic agents like Nitric Oxide,
Milrinone, Sildenaﬁl, and inhaled Prostacycline.
Table 7 Some demographic, clinical and hemodynamic ﬁndings of the studied cases.
Diagnosis Age
(months)
SaO2
(RA)
PVRI
(room air)
(WU/m2)
PVRI 100%
O2 (WU/m2)
Preoperative
Catheterization
(PASP mmHg)
Postoperative
TR (PSPG mmHg)
Current Status
VSD,PDA 11 95 16.6 6.6 86 50 Asymptomatic
VSD 90 96 3 71 70 Asymptomatic
VSD, ASD 120 99 11.5 5 112 50 Asymptomatic
CAVSD 19 75 18.5 6.6 100 75 Lost to follow up
CAVSD 17 95 6.5 1.2 75 55 Lost to follow up
Predicting operability in children with acyanotic congenital heart diseases and severe pulmonary hypertension 71It needs to be emphasized here that pulse oximetry based
criterion is a surrogate for PVRI criterion and therefore, has
similar limitations. In this series 5 operated patients continued
to have more than half systemic pulmonary hypertension as
estimated by velocity of tricuspid regurgitation jet by continu-
ous wave Doppler (Table 7). In two cases, protocol for opera-
bility was violated as SaO2 was <83% and PVRI was
>6 WU/m2 (CAVSD patient) and PVRI was >6 WU/m2 in
the case having VSD, and therefore, residual pulmonary
hypertension is not surprising. The remaining 3(4%) out of
69 patients who were operated continue to have residual
pulmonary arterial hypertension, though improved from
baseline. Similar observations have been made previously by
others.3,14,15
Outlook of pulmonary hypertension is better than in the
past due to availability of pulmonary vasodilator therapy. In
our series one patient is receiving low dose Sildenaﬁl and Bos-
entan, the other two are being closely observed without any
pulmonary vasodilator therapy and all are asymptomatic at
present. Two patients were lost to follow up but both were
asymptomatic at the time of last clinic visit. An additional
safeguard that may improve long term outlook of such pa-
tients would be to leave a mandatory sufﬁcient fenestration
in the atrial septum for all CAVSD patients and in VSD pa-
tient older than 2 years of age. Additional stringent criteria
suggested by Clapp3 who did the PVRI in room air only with-
out testing the oxygen reactivity, are probably not a preferable
strategy in our opinion. His approach would potentially im-
prove the speciﬁcity of identifying truly operable patients but
sensitivity will likely become excessively poor and might actu-
ally declare operable patients as inoperable.
Conclusion
In children less than 10 years of age, operability indication for
patients with VSD and CAVSD, suspected of having signiﬁ-
cant pulmonary vascular disease may be determined solely
by SaO2 measured by pulse oximetry and without measuring
PVRI by cardiac catheterization. Measurement of PVRI is
indicated if SaO2 is <83% in cases of CAVSD and <94%
in cases of ventricular septal defect.
Limitations of pulse oximetry
Several factors should be considered with the use of pulse
oximetry, since these variables will either alter the accuracy
of the readings or may cause harm to the patient. These fac-
tors include changes in the strength of the arterial pulse,
body movements, dyshemoglobinemias, plasma bilirubin,color interferences, venous pulsations, and several physical
factors. Awareness of these variations will help the clinician
become more knowledgeable in the use of the pulse
oximeter.22
Conﬂict of interest
None declared.
References
1. Blackstone EH, Kirklin JW, Bradley EL, DuShane JW, Appel-
baum A. Optimal age and results in repair of large ventricular
septal defects. J Thorac Cardiovasc Surg 1976;72(5):661–79.
2. Rose ML, Strange G, King I, Arnup S, Vidmar S, O’Donnell C,
Kermeen F, Grigg L, Weintraub RG, Celermajer DS. Congenital
heart disease-associated pulmonary arterial hypertension: pre-
liminary results from a novel registry. Int. Med J.
2012;42(8):874–9.
3. Clapp S, Rerry BL, Farooqi ZQ, Jackson WL, Karpawich PP,
Hakimi M, et al. Down’s syndrome, complete atrioventricular
canal, and pulmonary vascular obstructive disease. J Thorac
Cardiovasc Surg 1990;100(1):115–21.
4. Thiene G, Mazzucco A, Grisolia EF, Bartolotti U, Stellin G,
Chioin R, et al. Postoperative pathology of complete atrioven-
tricular defects. J Thorac Cardiovasc Surg 1982;83(6):891–900.
5. Atz AM, Hawkins JA, Lu M, Cohen MS, Colan SD, Jaggers J,
et al. Surgical management of complete atrioventricular septal
defect: associations with surgical technique, age, and trisomy 21. J
Thorac Cardiovasc Surg 2011;141(6):1371–9.
6. WHO Expert Committee. Health manpower requirements for the
achievement of health for all by year 2000 through primary
healthcare. Report of a WHO Expert Committee. WHO Tech,
Report 1985;717:792.
7. Francis B, Krishnamoorthy KM, Harikrishnan S, Padmakumar
K, Nair K. Long-term outcome of patients operated for large
ventricular septal defects with increased pulmonary vascular
resistance. Indian Heart J 2003;55(2):161–6.
8. Yamaki S, Yasui H, Kado H, Yonenaga K, Nakamura Y, Kikuchi
T, et al. Pulmonary vascular disease and operative indications in
complete atrioventricular canal defect in early infancy. J Thorac
Cardiovasc Surg 1993;106(3):398–405.
9. Kalogeropoulos AP, Martin RP. Visual assessment of left
ventricular function in the era of high deﬁnition: the machine
and the eye of the beholder. J Am Soc Echocardiogr
2010;23(3):265–6.
10. Schiller NB, Shah PM, Crawford M, et al. Recommendations for
quantitation of the left ventricle by two-dimensional echocardi-
ography. American Society of Echocardiography Committee on
Standards, Subcommittee on Quantitation of Two-Dimensional
Echocardiograms. J Am Soc Echocardiogr 1989;2:358–67.
11. Trowitzsch Eckardt, Colan Steven, Sanders Stephen. Two-dimen-
sional echocardiographic evaluation of right ventricular size and
72 S. Deraz et al.function in newborns with severe right ventricular outﬂow tract
obstruction. JACC 1985;388–93.
12. Mullins Charles. Hemodynamics, data acquisition, and interpre-
tation. In: Mullin Charles, editor. Cardiac catheterization in
congenital heart diseases: Pediatric and adult. Blackwell publish-
ing; 2006. p. 272–324.
13. Yamaki S, Mohri H, Haneda K, Endo M, Akimoto H. Indications
for surgery based on lung biopsy in cases of ventricular septal
defect and/or patent ductus arteriosus with severe pulmonary
hypertension. Chest 1989;96(1):31–9.
14. Yamaki S, Abe A, Tabayashi K, Endo M, Mohri H, Takahashi T.
Inoperable pulmonary vascular disease in infants with congenital
heart disease. Ann Thorac Surg 1998;66(5):1565–70.
15. Gorenﬂo M, Ullmann M, Sebening C, Brockmeier K, Hagl S,
Ulmer HE, et al. The index of pulmonary vascular disease in
children with congenital heart disease: relationship to clinical and
haemodynamic ﬁndings. Virchows Arch 2002 Sep;441(3):264–70.
16. Kirklin JW, Karp RB, Bargeron Jr LM. Surgical treatment of
ventricular septal defect. In: Sabiston DC, Spencer FC, editors.
Gibbonıs surgery of the chest. Philadelphia: WB Saunders Co.;
1976. p. 1035–6.
17. Momma K, Takao A, Ando M, Nakazawa M, Takamlzawa K.
Natural and post-operative history of pulmonary vascularobstruction: associated with ventricular septal defect. Jpn Circ J
1981;45(2):230–7.
18. David T, Henry W, Ronald W, Howard M, Corneli, John P,
Kovalchin et al. Inhaled Nitric Oxide as a Preoperative Test
(INOP Test I) The INOP Test Study Group. Circulation.
2002;106-76-I-81.
19. Bergersen L, Gauvreau K, Lock JE, Jenkins KJ. A Risk adjusted
method for comparing adverse outcomes among practitioners in
pediatric and congenital cardiac catheterization. Congenital Heart
Dis 2008;3(4):230–40.
20. Yilmazer MM, Ustyol A, Gu¨ven B, Oner T, Demirpenc¸e S,
Dokso¨z O, et al. Complications of cardiac catheterization in
pediatric patients: a single center experience. Turk J Pediatr
2012;54(5):478–85.
21. Zellers TM, Zehr R, Weinstein E, Leonard SJ, Ring WS, Nikaidoh
H. Two dimensional and Doppler echocardiography alone can
adequately deﬁne preoperative anatomy and hemodynamic status
before repair of complete atrioventricular septal defect in infants
<1 year old. JACC 1994;24(6):1565–70.
22. Jensen LA, Onyskiw JE, Prasad NG. Meta-analysis of arterial
oxygen saturation monitoring by pulse oximetry in adults. Heart
Lung 1998;27(6):387–408.
